PMID: 924894Sep 1, 1977

Ribostamycin, as an intermediate in the biosynthesis of neomycin

The Journal of Antibiotics
H BaudL Penasse

Abstract

A mutant of a neomycin-producting Streptomyces fradiae was found which synthesizes ribostamycin instead of neomycin. After a reverse mutation new colonies were obtained producting neomycin again. Ribostamycin might thus be considered as an intermediate in the biosynthesis of neomycin.

Citations

Jan 9, 2007·Chembiochem : a European Journal of Chemical Biology·Fanglu HuangJonathan B Spencer
Jul 31, 2007·Applied Microbiology and Biotechnology·Laxmi Prasad ThapaJae Kyung Sohng
Mar 5, 2015·Chemical Society Reviews·Sherif I ElshahawiJon S Thorson
Nov 23, 2006·Natural Product Reports·Nicholas M Llewellyn, Jonathan B Spencer
Mar 29, 2007·Natural Product Reports·Patricia M Flatt, Taifo Mahmud

Related Concepts

Antibiotics
Fermentation
Neomycin Palmitate
SF-733
Streptomyces

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.